Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hirsch

Showing results (281-290 of 350) with videos related to

Pageof 35
Sort By:
Circulation|June 3, 2004
Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapyMark A Creager, Daniel W Jones, J Donald Easton, et al.
JAMA|January 13, 2006
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisDeepak L Bhatt, P Gabriel Steg, E Magnus Ohman, et al.
Critical Pathways in Cardiology|September 4, 2009
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH RegistryAmit Kumar, Gregg C Fonarow, Kim A Eagle, et al.
Journal of Internal Medicine|March 10, 2010
Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery diseaseL Mechtouff, E Touzé, P G Steg, et al.
The Journal of Antimicrobial Chemotherapy|February 10, 2007
Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skinF Jacobsen, A Mohammadi-Tabrisi, T Hirsch, et al.
American Heart Journal|June 11, 2003
Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trialSanjay Rajagopalan, Emile Mohler, Robert J Lederman, et al.
European Heart Journal|November 11, 2008
Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registryRajendra H Mehta, Deepak L Bhatt, Ph Gabriel Steg, et al.
Vascular Medicine (London, England)|October 8, 2009
Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) studyUlf G Bronas, Alan T Hirsch, Timothy Murphy, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Stroke|October 28, 2006
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registryEmmanuel Touzé, Jean-Louis Mas, Joachim Röther, et al.
Pageof 35

Showing results (281-290 of 350) with videos related to

Sort By:
Pageof 35
Circulation|June 3, 2004
Atherosclerotic Vascular Disease Conference: Writing Group V: medical decision making and therapyMark A Creager, Daniel W Jones, J Donald Easton, et al.
JAMA|January 13, 2006
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosisDeepak L Bhatt, P Gabriel Steg, E Magnus Ohman, et al.
Critical Pathways in Cardiology|September 4, 2009
Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH RegistryAmit Kumar, Gregg C Fonarow, Kim A Eagle, et al.
Journal of Internal Medicine|March 10, 2010
Worse blood pressure control in patients with cerebrovascular or peripheral arterial disease compared with coronary artery diseaseL Mechtouff, E Touzé, P G Steg, et al.
The Journal of Antimicrobial Chemotherapy|February 10, 2007
Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skinF Jacobsen, A Mohammadi-Tabrisi, T Hirsch, et al.
American Heart Journal|June 11, 2003
Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trialSanjay Rajagopalan, Emile Mohler, Robert J Lederman, et al.
European Heart Journal|November 11, 2008
Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registryRajendra H Mehta, Deepak L Bhatt, Ph Gabriel Steg, et al.
Vascular Medicine (London, England)|October 8, 2009
Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) studyUlf G Bronas, Alan T Hirsch, Timothy Murphy, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Stroke|October 28, 2006
Impact of carotid endarterectomy on medical secondary prevention after a stroke or a transient ischemic attack: results from the Reduction of Atherothrombosis for Continued Health (REACH) registryEmmanuel Touzé, Jean-Louis Mas, Joachim Röther, et al.
Pageof 35